Abstract
Tailored activity pacing could help manage fatigue and improve physical activity. How-ever, little is known about how to tailor activity pacing for people with multiple sclerosis. This study aims to evaluate the effect of a tailored activity pacing intervention on fatigue and physical activity behaviours in adults with multiple sclerosis. Twenty-one adults with multiple sclerosis, stratified by age and gender, are randomly allocated to either a tailored pacing or control group. Participants wear an accelerometer for seven days that measures physical activity behaviours, and self-report fatigue at the baseline and four-week follow-up. Physical activity behaviours are assessed by exam-ining activity level (seven-day average activity counts per minute) and activity variability (seven-day average highest activity counts each day divided by activity counts on that day). The intervention improves activity levels (Mean difference = 40.91; 95% Confidence Interval [CI] (3.84–77.96); p = 0.03) and lessens activity variability (Mean difference = –0.63; 95% CI (−1.25–0.02); p = 0.04). No significant effect is found for fatigue (Mean difference = –0.36; 95% CI (−1.02–0.30); p = 0.27). This investigation shows that tailoring activity pacing based on physical activity behaviours and fatigue is effective in improving physical activity levels, without exacerbating fatigue symptoms.
Original language | English |
---|---|
Article number | 17 |
Pages (from-to) | 1-10 |
Journal | International Journal of Environmental Research and Public Health |
Volume | 18 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jan 2021 |
Externally published | Yes |
Funding
The authors would like to thank all participants for their contribution to the study. Furthermore, we would like to thank Multiple Sclerosis-UK (a national charity, based in Colchester, which supports people with multiple sclerosis and who regularly run exercise classes for people with multiple sclerosis) and Multiple Sclerosis Society local group in Colchester, for their support in the study.
Funders | Funder number |
---|---|
Multiple Sclerosis Society |